{"title": "La farmac\u00e9utica espa\u00f1ola Zendal y la instituci\u00f3n americana IAVI se asocian para la \u00faltima fase de ensayos cl\u00ednicos de la vacuna contra la tuberculosis MTBVAC", "author": null, "url": null, "hostname": null, "description": "La farmac\u00e9utica espa\u00f1ola Zendal y la instituci\u00f3n americana IAVI se asocian para la \u00faltima fase de ensayos cl\u00ednicos de la vacuna contra la tuberculosis MTBVAC", "sitename": null, "date": "2021-07-13", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "La biofarmac\u00e9utica espa\u00f1ola Biofabri e IAVI -organizaci\u00f3n internacional sin \u00e1nimo de lucro centrada en el desarrollo de vacunas y anticuerpos contra enfermedades infecciosas y de la pobreza- anunciaron hoy su uni\u00f3n para avanzar en los ensayos cl\u00ednicos de eficacia de la vacuna espa\u00f1ola contra la tuberculosis MTBVAC. La vacuna, dise\u00f1ada por el investigador Dr. Carlos Mart\u00edn de la Universidad de Zaragoza, est\u00e1 siendo fabricada y desarrollada por Biofabri, filial del Grupo Zendal, en colaboraci\u00f3n con la Universidad de Zaragoza, IAVI y la Iniciativa de vacunas contra la tuberculosis (TBVI por sus siglas en ingl\u00e9s).\nMTBVAC concluir\u00e1 este a\u00f1o la evaluaci\u00f3n de la Fase II siendo una de las vacunas candidatas m\u00e1s prometedoras en el actual pipeline mundial de vacunas contra la tuberculosis. La \u00fanica vacuna contra la tuberculosis disponible en la actualidad, el bacilo de Calmette-Gu\u00e9rin (BCG) fue, desarrollada hace 100 a\u00f1os y tiene una eficacia limitada para prevenir la tuberculosis pulmonar en adultos, quienes, junto con los adolescentes, son los responsables de la propagaci\u00f3n de la enfermedad. La primera dosis de la vacuna BCG se administr\u00f3 har\u00e1 100 a\u00f1os el pr\u00f3ximo domingo 18 de julio.\nEste anuncio entre Zendal e IAVI se produce en medio del ritmo hist\u00f3rico de desarrollo de nuevas vacunas contra el COVID-19.\n\u201cLa urgencia mundial de vacunas contra el COVID-19 est\u00e1 recibiendo merecidamente una atenci\u00f3n sin precedentes. Al mismo tiempo, este enfoque global en el control de enfermedades es una oportunidad para hacer un esfuerzo adicional y tratar de erradicar tambi\u00e9n otras enfermedades infecciosas como es la tuberculosis que, una vez que el COVID-19 retroceda, recuperar\u00e1 su posici\u00f3n como la principal causa de enfermedades infecciosas\u201d, subray\u00f3 Mark Feinberg, presidente y director ejecutivo de IAVI.\n\u201cCon el COVID-19 hemos visto que la financiaci\u00f3n adecuada y las asociaciones p\u00fablico-privadas son esenciales para el desarrollo r\u00e1pido y con \u00e9xito de nuevas vacunas. Del mismo modo, un esfuerzo conjunto internacional ser\u00e1 fundamental para el desarrollo de una nueva vacuna eficaz contra la tuberculosis. Estamos esperanzados en obtener el apoyo de patrocinadores y socios, del \u00e1mbito de la salud mundial, tanto p\u00fablicos como privados, para impulsar esta prometedora vacuna que tiene el potencial de abordar necesidades urgentes no resueltas y atajar as\u00ed la epidemia de tuberculosis \".\nLa Asociaci\u00f3n de Ensayos Cl\u00ednicos de Europa y Pa\u00edses en Desarrollo (EDCTP por sus siglas en ingl\u00e9s) se ha comprometido a apoyar el ensayo de Fase III de MTBVAC en reci\u00e9n nacidos, previsto para comenzar en 2022 en varios pa\u00edses africanos. IAVI apoyar\u00e1 el desarrollo y una mayor movilizaci\u00f3n de fondos para el ensayo en reci\u00e9n nacidos as\u00ed como en adolescentes / adultos.\n\u201cDesde Biofabri y el grupo Zendal estamos muy comprometidos con el desarrollo de esta vacuna por lo que nos satisface enormemente poder contar con el respaldo de dos organizaciones internacionales de prestigio como IAVI y TBVI en el objetivo com\u00fan de conseguir una vacuna contra la tuberculosis disponible en todo el mundo\u201d, dijo Esteban Rodr\u00edguez, CEO de Biofabri.\n\u201cEstamos orgullosos de que la cepa MTBVAC haya sido dise\u00f1ada aqu\u00ed en Espa\u00f1a, y soy cautelosamente optimista de que los prometedores datos tanto de las pruebas anteriores como las que est\u00e1n en curso, demuestren que estamos avanzando en la direcci\u00f3n correcta. Se est\u00e1n realizando estudios de fase II a diferentes dosis en adultos y reci\u00e9n nacidos y no se han identificado problemas de seguridad, lo cual es alentador. Tras estos estudios se seleccionar\u00e1 la dosis definitiva para avanzar en los siguientes estudios cl\u00ednicos -de eficacia- y si los resultados de esos ensayos dan sus frutos, tambi\u00e9n estaremos igualmente orgullosos de fabricar desde Biofabri una vacuna que salve vidas \".\nSi se demuestra que MTBVAC es segura y eficaz, Biofabri, en asociaci\u00f3n con IAVI, TBVI y Unizar, garantizar\u00e1n que la vacuna MTBVAC se fabrique y suministre en cantidades suficientes a reci\u00e9n nacidos, beb\u00e9s, adolescentes y adultos y sea accesible y a precios asequibles en los pa\u00edses de ingresos medianos y bajos.\nTB y COVID-19\nLa tuberculosis ha sido la principal causa de muerte por enfermedades infecciosas en el mundo, matando aproximadamente a 1,4 millones de personas cada a\u00f1o, el 10 por ciento de las cuales son ni\u00f1os. Estos n\u00fameros han sido superados solo por COVID-19 en los \u00faltimos dos a\u00f1os. Alrededor de 10 millones de personas enfermaron de tuberculosis en 2019, y la enfermedad es una de las diez principales causas de muerte en todo el mundo.\nCOVID-19 ha revertido los avances anteriores en la respuesta a la tuberculosis en 10 a\u00f1os, lo que ha provocado una disminuci\u00f3n significativa en la detecci\u00f3n de casos de tuberculosis. La Alianza Alto a la Tuberculosis estima que se producir\u00e1n 1,4 millones de muertes por tuberculosis adicionales durante los pr\u00f3ximos cuatro a\u00f1os debido al COVID-19. Una vacuna contra la tuberculosis vacuna es m\u00e1s necesaria y urgente que nunca.\nLa Tuberculosis farmacorresistente / multirresistente (TB DR / MDR por sus siglas en ingl\u00e9s) se est\u00e1 convirtiendo en un problema creciente, con aproximadamente 465.000 casos en 2019. El tratamiento de la TB DR / MDR es arduo, costoso y no siempre exitoso. Una vacuna que prevenga la enfermedad de la tuberculosis tendr\u00eda un gran impacto en el problema de la tuberculosis DR / MDR.\nMTBVAC\nMTBVAC es la \u00fanica vacuna viva atenuada contra Mycobacterium tuberculosis en desarrollo. Actualmente, se est\u00e1 desarrollando con dos prop\u00f3sitos: como una vacuna m\u00e1s eficaz y potencialmente m\u00e1s duradera que la BCG para reci\u00e9n nacidos, y por otra parte para la prevenci\u00f3n de la enfermedad tuberculosa en adultos y adolescentes, para quienes actualmente no existe vacuna eficaz.\nHay dos ensayos de fase II en curso, uno apoyado por EDCTP y patrocinado por Biofabri en beb\u00e9s en Sud\u00e1frica, y otro patrocinado por IAVI y apoyado por los Institutos Nacionales de Salud de EE. UU. y el Departamento de Defensa de EE. UU. a trav\u00e9s de su Programa de Investigaci\u00f3n M\u00e9dica Dirigido por el Congreso. Los resultados se esperan para finales de 2021.\nUn estudio publicado a principios de 2021 (White et al., NPJ Vaccines 2021) mostr\u00f3 que una sola dosis de MTBVAC proporciona una protecci\u00f3n significativamente mejor contra la exposici\u00f3n a aerosoles a Mycobacterium tuberculosis en macacos rhesus en comparaci\u00f3n con BCG a la misma dosis. Esto confirma que las respuestas inmunol\u00f3gicas inducidas despu\u00e9s de la vacunaci\u00f3n con MTBVAC en macacos rhesus reflejan los mismos resultados que los ensayos cl\u00ednicos de fase I de MTBVAC.\nBiofabri considera a IAVI como un socio crucial para el desarrollo de esta vacuna candidata de cara a los siguientes estudios de eficacia para neonatos / lactantes y adolescentes / adultos. IAVI apoyar\u00e1 a Biofabri en la planificaci\u00f3n del acceso para la indicaci\u00f3n neonatal / infantil y en el desarrollo e implementaci\u00f3n de los estudios para adolescentes y adultos. Los socios est\u00e1n buscando activamente financiaci\u00f3n que apoye el desarrollo cl\u00ednico para la indicaci\u00f3n de adolescentes / adultos.\nUn proyecto global\nEste acuerdo da un paso m\u00e1s en el avance del desarrollo de una prometedora vacuna candidata contra la tuberculosis, especialmente para pa\u00edses en desarrollo de ingresos bajos y medios, en un proyecto en el que los siguientes aliados juegan un papel fundamental:\nIAVI es una organizaci\u00f3n de investigaci\u00f3n cient\u00edfica sin fines de lucro con sede en los EE. UU. y con sedes en Europa, \u00c1frica e India que desarrolla vacunas y anticuerpos para el VIH, la tuberculosis, las enfermedades infecciosas emergentes (incluido COVID-19) y otras enfermedades desatendidas con el objetivo de proporcionar un acceso global. Ha trabajado en la mayor\u00eda de las principales candidatas vacunales contra la tuberculosis que se encuentran actualmente en desarrollo cl\u00ednico y cuenta con un equipo especializado en tuberculosis en Sud\u00e1frica.\nBiofabri es una empresa biofarmac\u00e9utica creada en 2008 con el objetivo de investigar, desarrollar y fabricar vacunas para humanos. BIOFABRI se centra en la salud humana, tiene una s\u00f3lida capacidad t\u00e9cnica, de I+D y de fabricaci\u00f3n, as\u00ed como una s\u00f3lida trayectoria en biotecnolog\u00eda. Biofabri es responsable de la fabricaci\u00f3n y el desarrollo cl\u00ednico de MTBVAC.\nBiofabri pertenece al grupo Zendal, grupo empresarial biofarmac\u00e9utico espa\u00f1ol formado por 7 empresas especializado en el desarrollo, fabricaci\u00f3n y comercializaci\u00f3n de vacunas y otros productos biotecnol\u00f3gicos para la salud humana y animal.\nTBVI. La Iniciativa de Vacunas contra la Tuberculosis es una fundaci\u00f3n sin fines de lucro que permite el descubrimiento y desarrollo de nuevas vacunas contra la tuberculosis, seguras y eficaces que sean accesibles y asequibles para todas las personas. Como Asociaci\u00f3n de Desarrollo de Productos (PDA), TBVI integra, traduce y prioriza los esfuerzos de I + D para descubrir y desarrollar vacunas y biomarcadores contra la tuberculosis para su uso global. TBVI proporciona servicios esenciales que respaldan los esfuerzos de I + D de sus socios: 50 socios del mundo acad\u00e9mico, institutos de investigaci\u00f3n e industria privada del campo de la tuberculosis.\nUNIZAR. La Universidad de Zaragoza es el principal centro de innovaci\u00f3n tecnol\u00f3gica del Valle del Ebro. Participa en diferentes programas de intercambio, colaborando con universidades y centros de investigaci\u00f3n de Europa, Latinoam\u00e9rica y Estados Unidos. Microbi\u00f3logos de la universidad perteneciente al CIBERES lideraron la investigaci\u00f3n y posterior descubrimiento de la vacuna experimental MTBVAC.", "language": null, "image": null, "pagetype": null, "links": ["http://biotech-spain.com/en/", null, "http://biotech-spain.com/en/", "http://biotech-spain.com/en/articles", "http://biotech-spain.com/en/directory", "http://biotech-spain.com/en/admin/", "http://biotech-spain.com/en/contact", "/en", "/es", "https://www.facebook.com/biotech.in.spain", "https://twitter.com/Biotech_Spain", "https://plus.google.com/+Biotechspain-Biotecnolog\u00eda-en-Espa\u00f1a", "https://www.linkedin.com/company/biotech-spain/", "http://biotech-spain.com/en/", "http://biotech-spain.com/en/articles", "http://biotech-spain.com/en/articles?category=vaccines", "http://biotech-spain.com/en/articles?category=research-services-and-supp", "http://biotech-spain.com/en/articles?category=research-network", "http://biotech-spain.com/en/articles?category=infections", "http://biotech-spain.com/en/articles?category=pharmacy", "http://biotech-spain.com/en/articles?category=clinical-trials", "http://biotech-spain.com/en/articles?category=research-centers", "http://biotech-spain.com/en/articles?category=biodrugs", "http://biotech-spain.com/en/articles/la-farmac-utica-espa-ola-zendal-y-la-instituci-n-americana-iavi-se-asocian-para-la-ltima-fase-de-ensayos-cl-nicos-de-la-vacuna-contra-la-tuberculosis-mtbvac/", "http://biotech-spain.com/en/directory/asebio/", "http://biotech-spain.com/en/articles/tags/zenda", "http://biotech-spain.com/en/articles/tags/vacunas", "http://biotech-spain.com/en/articles/tags/tuberculosis", "http://biotech-spain.com/en/articles/tags/vacuna+experimental", "http://biotech-spain.com/en/articles/tags/mtbvac", "https://asebio.com/actualidad/noticias/la-farmaceutica-espanola-zendal-y-la-institucion-americana-iavi-se-asocian-para", "http://biotech-spain.com/en/admin/login", "http://biotech-spain.com/en/admin/login", "http://biotech-spain.com/en/articles/el-diagn-stico-gen-tico-neonatal-mejora-la-esperanza-de-vida-de-ni-os-con-una-inmunodeficiencia-letal/", "http://biotech-spain.com/en/articles/m-s-de-1-500-cambios-epigen-ticos-en-el-esperma-asociados-a-la-edad-paterna/", "http://biotech-spain.com/en/articles/tuneable-reverse-photochromes-in-the-solid-state-/", "#tab-1", "#tab-2", "http://biotech-spain.com/en/articles/eosin-filos-qu-significa-tener-valores-altos-o-bajos-/", "http://biotech-spain.com/en/articles/tiny-sea-creatures-reveal-the-ancient-origins-of-neurons/", "http://biotech-spain.com/en/articles/tiny-sea-creatures-reveal-the-ancient-origins-of-neurons/", "http://biotech-spain.com/en/articles/los-pacientes-con-psoriasis-grave-tienen-mayor-riesgo-cardiovascular/", "http://biotech-spain.com/en/articles/las-pruebas-moleculares-permiten-detectar-de-forma-m-s-eficaz-el-c-ncer-de-endometrio-y-evitar-histerectom-as-innecesarias-en-mujeres-con-sangrado-post-menop-usico/", "http://biotech-spain.com/en/articles/a-study-by-ibs-granada-reveals-that-exposure-to-perfluorinated-compounds-pfas-affects-the-reproductive-health-of-adolescents/", "http://biotech-spain.com/en/articles/key-protein-identified-in-fat-function-and-obesity-related-problems/", "http://biotech-spain.com/en/articles/incliva-y-uv-investigan-la-p-rdida-de-conectividad-entre-el-hipocampo-izquierdo-y-derecho-en-la-enfermedad-de-alzheimer/", "http://biotech-spain.com/en/articles/vhio-led-retrospective-study-evaluates-the-clinical-and-genomic-features-of-early-onset-pancreatic-cancer-/", "http://biotech-spain.com/en/articles/a-portable-sensor-could-detect-cancerous-tumors/", "http://biotech-spain.com/en/articles/tags/cancer", "http://biotech-spain.com/en/articles/tags/covid-19", "http://biotech-spain.com/en/articles/tags/alzheimer", "http://biotech-spain.com/en/articles/tags/investigaci%c3%b3n", "http://biotech-spain.com/en/articles/tags/salud", "http://biotech-spain.com/en/articles/tags/coronavirus", "http://biotech-spain.com/en/articles/tags/covid19", "http://biotech-spain.com/en/terms", "http://biotech-spain.com/en/privacy", "https://www.facebook.com/biotech.in.spain", "https://twitter.com/Biotech_Spain", "https://plus.google.com/+Biotechspain-Biotecnolog\u00eda-en-Espa\u00f1a", "https://www.linkedin.com/company/biotech-spain/", "http://biotech-spain.com/en/articles?category=substance-abuse", "http://biotech-spain.com/en/articles?category=agrobiotechnology", "http://biotech-spain.com/en/articles?category=food-sub", "http://biotech-spain.com/en/articles?category=animal-food-feed", "http://biotech-spain.com/en/articles?category=functional-food", "http://biotech-spain.com/en/articles?category=analgesia-pain", "http://biotech-spain.com/en/articles?category=associations", "http://biotech-spain.com/en/articles?category=biobanks", "http://biotech-spain.com/en/articles?category=bioclusters", "http://biotech-spain.com/en/articles?category=biofuels", "http://biotech-spain.com/en/articles?category=biodrugs", "http://biotech-spain.com/en/articles?category=bioinformatics", "http://biotech-spain.com/en/articles?category=cellular-and-molecular-b", "http://biotech-spain.com/en/articles?category=systems-biology", "http://biotech-spain.com/en/articles?category=evolutionary-biology", "http://biotech-spain.com/en/articles?category=synthetic-biology", "http://biotech-spain.com/en/articles?category=biomarkers", "http://biotech-spain.com/en/articles?category=biomaterials", "http://biotech-spain.com/en/articles?category=marine-based-biotechnology", "http://biotech-spain.com/en/articles?category=business-angels", "http://biotech-spain.com/en/articles?category=cancer", "http://biotech-spain.com/en/articles?category=stem-cells", "http://biotech-spain.com/en/articles?category=cardiovascular-and-cir", "http://biotech-spain.com/en/articles?category=research-centers", "http://biotech-spain.com/en/articles?category=private-clinic", "http://biotech-spain.com/en/articles?category=communication-media", "http://biotech-spain.com/en/articles?category=consultancy", "http://biotech-spain.com/en/articles?category=biologic-control-plagues-", "http://biotech-spain.com/en/articles?category=quality-control", "http://biotech-spain.com/en/articles?category=corporate-investor", "http://biotech-spain.com/en/articles?category=cosmetics", "http://biotech-spain.com/en/articles?category=cell-culture", "http://biotech-spain.com/en/articles?category=gm-crops", "http://biotech-spain.com/en/articles?category=biological-defense", "http://biotech-spain.com/en/articles?category=dental", "http://biotech-spain.com/en/articles?category=dermatology", "http://biotech-spain.com/en/articles?category=muskuloskeletal", "http://biotech-spain.com/en/articles?category=biotechnology-kits", "http://biotech-spain.com/en/articles?category=software-development", "http://biotech-spain.com/en/articles?category=diagnostic-imaging", "http://biotech-spain.com/en/articles?category=medical-devices", "http://biotech-spain.com/en/articles?category=drug-delivery", "http://biotech-spain.com/en/articles?category=drug-development", "http://biotech-spain.com/en/articles?category=drug-discovery", "http://biotech-spain.com/en/articles?category=pregnancy-reproduction", "http://biotech-spain.com/en/articles?category=venture-capital-manageme", "http://biotech-spain.com/en/articles?category=energy", "http://biotech-spain.com/en/articles?category=bone-diseases", "http://biotech-spain.com/en/articles?category=chronic-diseases", "http://biotech-spain.com/en/articles?category=degenerative-diseases", "http://biotech-spain.com/en/articles?category=genetic-diseases", "http://biotech-spain.com/en/articles?category=hereditary-diseases", "http://biotech-spain.com/en/articles?category=inflamatory-diseases", "http://biotech-spain.com/en/articles?category=neurologic-diseases", "http://biotech-spain.com/en/articles?category=rares-diseases", "http://biotech-spain.com/en/articles?category=clinical-trials", "http://biotech-spain.com/en/articles?category=public-entity", "http://biotech-spain.com/en/articles?category=epidemiology", "http://biotech-spain.com/en/articles?category=epigenetics", "http://biotech-spain.com/en/articles?category=medical-and-surgica", "http://biotech-spain.com/en/articles?category=patient-monito", "http://biotech-spain.com/en/articles?category=manufacture-of-biotech", "http://biotech-spain.com/en/articles?category=manufacter-of-resins-to-purifi", "http://biotech-spain.com/en/articles?category=manufacture-and-commercialization-of-fermentation-or-biocatalysis", "http://biotech-spain.com/en/articles?category=manufacture-and-commercialization-of-enzymes-", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=manufacture-o", "http://biotech-spain.com/en/articles?category=manufa", "http://biotech-spain.com/en/articles?category=pharmacy", "http://biotech-spain.com/en/articles?category=pharmacogenomics", "http://biotech-spain.com/en/articles?category=public-financing", "http://biotech-spain.com/en/articles?category=investment-funds", "http://biotech-spain.com/en/articles?category=training", "http://biotech-spain.com/en/articles?category=foundatio", "http://biotech-spain.com/en/articles?category=foundation", "http://biotech-spain.com/en/articles?category=genomics", "http://biotech-spain.com/en/articles?category=hospitals", "http://biotech-spain.com/en/articles?category=infections", "http://biotech-spain.com/en/articles?category=engineering", "http://biotech-spain.com/en/articles?category=immunology", "http://biotech-spain.com/en/articles?category=healthcare-facilities-and", "http://biotech-spain.com/en/articles?category=scientific-t", "http://biotech-spain.com/en/articles?category=inter", "http://biotech-spain.com/en/articles?category=institutional-investor", "http://biotech-spain.com/en/articles?category=private-investor", "http://biotech-spain.com/en/articles?category=leasing", "http://biotech-spain.com/en/articles?category=environmental-cleanup-testing", "http://biotech-spain.com/en/articles?category=maintenance-cell-culture", "http://biotech-spain.com/en/articles?category=sales-marketing", "http://biotech-spain.com/en/articles?category=environment", "http://biotech-spain.com/en/articles?category=metabolomics", "http://biotech-spain.com/en/articles?category=microbiology", "http://biotech-spain.com/en/articles?category=nanotechnology", "http://biotech-spain.com/en/articles?category=neuroscience", "http://biotech-spain.com/en/articles?category=nutrition", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=oftalmology", "http://biotech-spain.com/en/articles?category=cost-optimization", "http://biotech-spain.com/en/articles?category=othe", "http://biotech-spain.com/en/articles?category=peptides", "http://biotech-spain.com/en/articles?category=science-tec", "http://biotech-spain.com/en/articles?category=probiotics", "http://biotech-spain.com/en/articles?category=blood-products", "http://biotech-spain.com/en/articles?category=disposable-medical-prod", "http://biotech-spain.com/en/articles?category=industrial-property-p", "http://biotech-spain.com/en/articles?category=proteins", "http://biotech-spain.com/en/articles?category=proteomics", "http://biotech-spain.com/en/articles?category=dna-tests", "http://biotech-spain.com/en/articles?category=diagnostic-tests", "http://biotech-spain.com/en/articles?category=scientific-publications", "http://biotech-spain.com/en/articles?category=chemistry", "http://biotech-spain.com/en/articles?category=human-resources", "http://biotech-spain.com/en/articles?category=research-network", "http://biotech-spain.com/en/articles?category=r", "http://biotech-spain.com/en/articles?category=animal-health", "http://biotech-spain.com/en/articles?category=women-s-health", "http://biotech-spain.com/en/articles?category=child-health", "http://biotech-spain.com/en/articles?category=mental-health", "http://biotech-spain.com/en/articles?category=senior-health", "http://biotech-spain.com/en/articles?category=healthy", "http://biotech-spain.com/en/articles?category=blood-and-lymphatic-system", "http://biotech-spain.com/en/articles?category=screening", "http://biotech-spain.com/en/articles?category=food-safety", "http://biotech-spain.com/en/articles?category=cro-cmo-services", "http://biotech-spain.com/en/articles?category=research-services-and-supp", "http://biotech-spain.com/en/articles?category=legal-services", "http://biotech-spain.com/en/articles?category=auditory-system", "http://biotech-spain.com/en/articles?category=digestive-system", "http://biotech-spain.com/en/articles?category=kidney-and-geni", "http://biotech-spain.com/en/articles?category=locomotive-system", "http://biotech-spain.com/en/articles?category=metabolic-sy", "http://biotech-spain.com/en/articles?category=central-nervous-system", "http://biotech-spain.com/en/articles?category=respiratory-and-pulmonary-sy", "http://biotech-spain.com/en/articles?category=laser-optical-systems", "http://biotech-spain.com/en/articles?category=cellular-therapy", "http://biotech-spain.com/en/articles?category=gene-therapy", "http://biotech-spain.com/en/articles?category=tissue-therapy", "http://biotech-spain.com/en/articles?category=toxicology", "http://biotech-spain.com/en/articles?category=technology-transfer", "http://biotech-spain.com/en/articles?category=transplant", "http://biotech-spain.com/en/articles?category=universities", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=vaccines", "http://biotech-spain.com/en/articles?category=", "http://biotech-spain.com/en/articles?category=venture-capital", "http://biotech-spain.com/en/articles?category=vitamins-and-nutri", "http://biotech-spain.com/en/articles?category=viral-vector", "http://biotech-spain.com/en/directory?category=substance-abuse", "http://biotech-spain.com/en/directory?category=agrobiotechnology", "http://biotech-spain.com/en/directory?category=food-sub", "http://biotech-spain.com/en/directory?category=animal-food-feed", "http://biotech-spain.com/en/directory?category=functional-food", "http://biotech-spain.com/en/directory?category=analgesia-pain", "http://biotech-spain.com/en/directory?category=associations", "http://biotech-spain.com/en/directory?category=biobanks", "http://biotech-spain.com/en/directory?category=bioclusters", "http://biotech-spain.com/en/directory?category=biofuels", "http://biotech-spain.com/en/directory?category=biodrugs", "http://biotech-spain.com/en/directory?category=bioinformatics", "http://biotech-spain.com/en/directory?category=cellular-and-molecular-b", "http://biotech-spain.com/en/directory?category=systems-biology", "http://biotech-spain.com/en/directory?category=evolutionary-biology", "http://biotech-spain.com/en/directory?category=synthetic-biology", "http://biotech-spain.com/en/directory?category=biomarkers", "http://biotech-spain.com/en/directory?category=biomaterials", "http://biotech-spain.com/en/directory?category=marine-based-biotechnology", "http://biotech-spain.com/en/directory?category=business-angels", "http://biotech-spain.com/en/directory?category=cancer", "http://biotech-spain.com/en/directory?category=stem-cells", "http://biotech-spain.com/en/directory?category=cardiovascular-and-cir", "http://biotech-spain.com/en/directory?category=research-centers", "http://biotech-spain.com/en/directory?category=private-clinic", "http://biotech-spain.com/en/directory?category=communication-media", "http://biotech-spain.com/en/directory?category=consultancy", "http://biotech-spain.com/en/directory?category=biologic-control-plagues-", "http://biotech-spain.com/en/directory?category=quality-control", "http://biotech-spain.com/en/directory?category=corporate-investor", "http://biotech-spain.com/en/directory?category=cosmetics", "http://biotech-spain.com/en/directory?category=cell-culture", "http://biotech-spain.com/en/directory?category=gm-crops", "http://biotech-spain.com/en/directory?category=biological-defense", "http://biotech-spain.com/en/directory?category=dental", "http://biotech-spain.com/en/directory?category=dermatology", "http://biotech-spain.com/en/directory?category=muskuloskeletal", "http://biotech-spain.com/en/directory?category=biotechnology-kits", "http://biotech-spain.com/en/directory?category=software-development", "http://biotech-spain.com/en/directory?category=diagnostic-imaging", "http://biotech-spain.com/en/directory?category=medical-devices", "http://biotech-spain.com/en/directory?category=drug-delivery", "http://biotech-spain.com/en/directory?category=drug-development", "http://biotech-spain.com/en/directory?category=drug-discovery", "http://biotech-spain.com/en/directory?category=pregnancy-reproduction", "http://biotech-spain.com/en/directory?category=venture-capital-manageme", "http://biotech-spain.com/en/directory?category=energy", "http://biotech-spain.com/en/directory?category=bone-diseases", "http://biotech-spain.com/en/directory?category=chronic-diseases", "http://biotech-spain.com/en/directory?category=degenerative-diseases", "http://biotech-spain.com/en/directory?category=genetic-diseases", "http://biotech-spain.com/en/directory?category=hereditary-diseases", "http://biotech-spain.com/en/directory?category=inflamatory-diseases", "http://biotech-spain.com/en/directory?category=neurologic-diseases", "http://biotech-spain.com/en/directory?category=rares-diseases", "http://biotech-spain.com/en/directory?category=clinical-trials", "http://biotech-spain.com/en/directory?category=public-entity", "http://biotech-spain.com/en/directory?category=epidemiology", "http://biotech-spain.com/en/directory?category=epigenetics", "http://biotech-spain.com/en/directory?category=medical-and-surgica", "http://biotech-spain.com/en/directory?category=patient-monito", "http://biotech-spain.com/en/directory?category=manufacture-of-biotech", "http://biotech-spain.com/en/directory?category=manufacter-of-resins-to-purifi", "http://biotech-spain.com/en/directory?category=manufacture-and-commercialization-of-fermentation-or-biocatalysis", "http://biotech-spain.com/en/directory?category=manufacture-and-commercialization-of-enzymes-", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=manufacture-o", "http://biotech-spain.com/en/directory?category=manufa", "http://biotech-spain.com/en/directory?category=pharmacy", "http://biotech-spain.com/en/directory?category=pharmacogenomics", "http://biotech-spain.com/en/directory?category=public-financing", "http://biotech-spain.com/en/directory?category=investment-funds", "http://biotech-spain.com/en/directory?category=training", "http://biotech-spain.com/en/directory?category=foundatio", "http://biotech-spain.com/en/directory?category=foundation", "http://biotech-spain.com/en/directory?category=genomics", "http://biotech-spain.com/en/directory?category=hospitals", "http://biotech-spain.com/en/directory?category=infections", "http://biotech-spain.com/en/directory?category=engineering", "http://biotech-spain.com/en/directory?category=immunology", "http://biotech-spain.com/en/directory?category=healthcare-facilities-and", "http://biotech-spain.com/en/directory?category=scientific-t", "http://biotech-spain.com/en/directory?category=inter", "http://biotech-spain.com/en/directory?category=institutional-investor", "http://biotech-spain.com/en/directory?category=private-investor", "http://biotech-spain.com/en/directory?category=leasing", "http://biotech-spain.com/en/directory?category=environmental-cleanup-testing", "http://biotech-spain.com/en/directory?category=maintenance-cell-culture", "http://biotech-spain.com/en/directory?category=sales-marketing", "http://biotech-spain.com/en/directory?category=environment", "http://biotech-spain.com/en/directory?category=metabolomics", "http://biotech-spain.com/en/directory?category=microbiology", "http://biotech-spain.com/en/directory?category=nanotechnology", "http://biotech-spain.com/en/directory?category=neuroscience", "http://biotech-spain.com/en/directory?category=nutrition", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=oftalmology", "http://biotech-spain.com/en/directory?category=cost-optimization", "http://biotech-spain.com/en/directory?category=othe", "http://biotech-spain.com/en/directory?category=peptides", "http://biotech-spain.com/en/directory?category=science-tec", "http://biotech-spain.com/en/directory?category=probiotics", "http://biotech-spain.com/en/directory?category=blood-products", "http://biotech-spain.com/en/directory?category=disposable-medical-prod", "http://biotech-spain.com/en/directory?category=industrial-property-p", "http://biotech-spain.com/en/directory?category=proteins", "http://biotech-spain.com/en/directory?category=proteomics", "http://biotech-spain.com/en/directory?category=dna-tests", "http://biotech-spain.com/en/directory?category=diagnostic-tests", "http://biotech-spain.com/en/directory?category=scientific-publications", "http://biotech-spain.com/en/directory?category=chemistry", "http://biotech-spain.com/en/directory?category=human-resources", "http://biotech-spain.com/en/directory?category=research-network", "http://biotech-spain.com/en/directory?category=r", "http://biotech-spain.com/en/directory?category=animal-health", "http://biotech-spain.com/en/directory?category=women-s-health", "http://biotech-spain.com/en/directory?category=child-health", "http://biotech-spain.com/en/directory?category=mental-health", "http://biotech-spain.com/en/directory?category=senior-health", "http://biotech-spain.com/en/directory?category=healthy", "http://biotech-spain.com/en/directory?category=blood-and-lymphatic-system", "http://biotech-spain.com/en/directory?category=screening", "http://biotech-spain.com/en/directory?category=food-safety", "http://biotech-spain.com/en/directory?category=cro-cmo-services", "http://biotech-spain.com/en/directory?category=research-services-and-supp", "http://biotech-spain.com/en/directory?category=legal-services", "http://biotech-spain.com/en/directory?category=auditory-system", "http://biotech-spain.com/en/directory?category=digestive-system", "http://biotech-spain.com/en/directory?category=kidney-and-geni", "http://biotech-spain.com/en/directory?category=locomotive-system", "http://biotech-spain.com/en/directory?category=metabolic-sy", "http://biotech-spain.com/en/directory?category=central-nervous-system", "http://biotech-spain.com/en/directory?category=respiratory-and-pulmonary-sy", "http://biotech-spain.com/en/directory?category=laser-optical-systems", "http://biotech-spain.com/en/directory?category=cellular-therapy", "http://biotech-spain.com/en/directory?category=gene-therapy", "http://biotech-spain.com/en/directory?category=tissue-therapy", "http://biotech-spain.com/en/directory?category=toxicology", "http://biotech-spain.com/en/directory?category=technology-transfer", "http://biotech-spain.com/en/directory?category=transplant", "http://biotech-spain.com/en/directory?category=universities", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=vaccines", "http://biotech-spain.com/en/directory?category=", "http://biotech-spain.com/en/directory?category=venture-capital", "http://biotech-spain.com/en/directory?category=vitamins-and-nutri", "http://biotech-spain.com/en/directory?category=viral-vector"]}